| 5.8 |
17.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 4.1 |
16.5 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 3.6 |
10.8 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 3.3 |
3.3 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.8 |
11.4 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 2.8 |
22.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 2.6 |
7.9 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 2.6 |
7.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 2.4 |
7.3 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 2.4 |
7.1 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.3 |
6.9 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 2.3 |
6.8 |
GO:0046959 |
habituation(GO:0046959) |
| 2.3 |
6.8 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 2.3 |
6.8 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.3 |
6.8 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 2.2 |
6.5 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 2.1 |
6.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.1 |
6.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.1 |
16.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 2.0 |
6.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 2.0 |
8.1 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.9 |
5.8 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.9 |
7.6 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.9 |
9.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 1.8 |
5.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 1.8 |
5.4 |
GO:0032847 |
positive regulation of neuron maturation(GO:0014042) regulation of cellular pH reduction(GO:0032847) |
| 1.8 |
7.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 1.8 |
5.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.8 |
3.5 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 1.7 |
6.9 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.7 |
13.3 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.7 |
3.3 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 1.6 |
9.9 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.6 |
4.7 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 1.6 |
4.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.5 |
4.6 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.5 |
7.6 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 1.5 |
1.5 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 1.5 |
3.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 1.5 |
11.8 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 1.5 |
13.3 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 1.4 |
7.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.4 |
7.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.4 |
8.3 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 1.4 |
5.5 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.4 |
2.7 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 1.3 |
4.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.3 |
4.0 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.3 |
1.3 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.3 |
3.9 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 1.3 |
10.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 1.3 |
6.5 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 1.3 |
10.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.3 |
1.3 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 1.3 |
1.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.3 |
18.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.2 |
1.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.2 |
3.7 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.2 |
4.9 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 1.2 |
4.9 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.2 |
3.7 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.2 |
1.2 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 1.2 |
3.6 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 1.2 |
4.8 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.2 |
10.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.2 |
7.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.2 |
4.7 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 1.2 |
3.5 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 1.2 |
4.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.2 |
4.7 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.2 |
3.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.2 |
1.2 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 1.1 |
4.5 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.1 |
6.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.1 |
3.4 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 1.1 |
3.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.1 |
3.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.1 |
2.2 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
| 1.1 |
2.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.1 |
4.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 1.1 |
3.2 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 1.1 |
6.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.1 |
13.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 1.0 |
4.2 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 1.0 |
7.2 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.0 |
15.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 |
3.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.0 |
5.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 1.0 |
8.0 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 1.0 |
2.0 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.0 |
1.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.0 |
3.9 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.0 |
9.7 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 1.0 |
4.8 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 1.0 |
2.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 1.0 |
3.8 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.9 |
2.8 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.9 |
3.8 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.9 |
2.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
3.7 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.9 |
11.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.9 |
2.8 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.9 |
6.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.9 |
3.7 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.9 |
9.1 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.9 |
2.7 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.9 |
0.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.9 |
2.7 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.9 |
1.8 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.9 |
2.6 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.9 |
2.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.9 |
6.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.9 |
6.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.9 |
1.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.9 |
2.6 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.9 |
2.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.8 |
1.7 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.8 |
5.1 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.8 |
3.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.8 |
2.5 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.8 |
2.5 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.8 |
5.0 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.8 |
2.5 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.8 |
4.9 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.8 |
9.0 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.8 |
4.0 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.8 |
3.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.8 |
3.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.8 |
2.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 |
2.4 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.8 |
1.6 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.8 |
1.6 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.8 |
0.8 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.8 |
2.3 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.8 |
4.6 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.8 |
3.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 |
2.3 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.8 |
0.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.8 |
0.8 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 |
2.3 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.8 |
2.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.8 |
3.0 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.8 |
6.1 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.8 |
2.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 |
3.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.7 |
3.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.7 |
2.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 |
2.9 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.7 |
2.9 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.7 |
1.5 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.7 |
5.9 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.7 |
2.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.7 |
0.7 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.7 |
2.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.7 |
3.6 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.7 |
2.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.7 |
2.1 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.7 |
4.2 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.7 |
4.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.7 |
6.3 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.7 |
2.1 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.7 |
6.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.7 |
2.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.7 |
1.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.7 |
2.1 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.7 |
3.4 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.7 |
1.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.7 |
8.8 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 |
2.0 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.7 |
1.3 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.7 |
7.9 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.7 |
2.0 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.7 |
2.6 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.7 |
2.6 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.7 |
2.0 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.7 |
3.9 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.6 |
2.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.6 |
7.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 |
3.2 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.6 |
1.9 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.6 |
0.6 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.6 |
0.6 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.6 |
1.9 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.6 |
5.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.6 |
2.5 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.6 |
7.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 |
1.9 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.6 |
3.8 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.6 |
3.7 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.6 |
1.9 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.6 |
8.7 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.6 |
3.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.6 |
1.8 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.6 |
1.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.6 |
6.7 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.6 |
1.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.6 |
1.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.6 |
6.6 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.6 |
1.8 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.6 |
3.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.6 |
3.0 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
0.6 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.6 |
1.8 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.6 |
2.9 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.6 |
1.7 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.6 |
1.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.6 |
2.9 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.6 |
1.7 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.6 |
2.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.6 |
1.1 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.6 |
1.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
1.7 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.6 |
2.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.6 |
2.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.6 |
0.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.6 |
1.7 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.6 |
6.7 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.6 |
1.7 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.5 |
2.7 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.5 |
4.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.5 |
1.6 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.5 |
2.7 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 |
2.7 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.5 |
4.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.5 |
1.6 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.5 |
5.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.5 |
1.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.5 |
1.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 |
15.7 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.5 |
1.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.5 |
2.6 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.5 |
0.5 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.5 |
15.1 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.5 |
4.1 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 0.5 |
0.5 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.5 |
0.5 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
1.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.5 |
3.1 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.5 |
4.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.5 |
1.0 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.5 |
1.0 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.5 |
2.0 |
GO:2000054 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.5 |
1.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
2.0 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.5 |
7.0 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.5 |
4.0 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.5 |
2.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 |
0.5 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.5 |
3.5 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
1.0 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
0.5 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.5 |
3.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 |
5.4 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.5 |
11.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.5 |
4.4 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.5 |
1.5 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.5 |
1.0 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.5 |
0.5 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.5 |
2.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.5 |
1.9 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.5 |
3.8 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.5 |
1.0 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.5 |
1.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 |
0.5 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.5 |
0.5 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.5 |
1.9 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.5 |
4.2 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.5 |
1.9 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 |
6.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.5 |
2.8 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
4.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 |
0.9 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.5 |
1.4 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.5 |
1.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.5 |
0.5 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.5 |
0.9 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.4 |
1.3 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.4 |
1.3 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.4 |
1.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.4 |
0.9 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.4 |
4.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 |
1.8 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.4 |
2.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
0.9 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
| 0.4 |
2.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
2.2 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.4 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
0.9 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.4 |
1.7 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 |
0.9 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.4 |
5.2 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.4 |
1.3 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.4 |
0.4 |
GO:0003181 |
atrioventricular valve morphogenesis(GO:0003181) |
| 0.4 |
2.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
2.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.4 |
3.4 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.4 |
3.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
0.8 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 |
1.7 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 |
2.5 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.4 |
2.5 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.4 |
1.7 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.4 |
1.7 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.4 |
2.9 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.4 |
1.2 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 |
4.9 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.4 |
0.8 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.4 |
9.0 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.4 |
2.9 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.4 |
1.2 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
1.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
1.6 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.4 |
2.4 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.4 |
0.8 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.4 |
7.1 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.4 |
2.0 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.4 |
2.0 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 |
1.6 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 |
1.9 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.4 |
1.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
4.2 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.4 |
1.5 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.4 |
3.8 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 |
1.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 |
1.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
0.8 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.4 |
0.8 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.4 |
1.5 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.4 |
1.1 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.4 |
3.7 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.4 |
3.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.4 |
1.5 |
GO:0046398 |
UDP-glucuronate metabolic process(GO:0046398) |
| 0.4 |
5.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
1.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.4 |
0.4 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.4 |
1.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.4 |
2.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
2.6 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.4 |
0.7 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.4 |
4.0 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.4 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.4 |
1.8 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.4 |
1.5 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.4 |
4.0 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.4 |
1.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 |
3.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.4 |
2.9 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.4 |
2.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
2.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.4 |
2.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
2.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.4 |
2.1 |
GO:0071872 |
response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.4 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.3 |
3.1 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.3 |
2.8 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 |
0.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.3 |
2.4 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.3 |
0.3 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 |
0.3 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.3 |
7.6 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
1.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
1.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
0.7 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 |
5.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
3.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
2.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.3 |
0.3 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 |
1.0 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.3 |
3.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.3 |
1.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
0.3 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.3 |
3.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 |
1.0 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.3 |
4.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.3 |
3.6 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.3 |
0.7 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 |
2.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
1.3 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.3 |
0.7 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.3 |
5.5 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.3 |
1.0 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.3 |
1.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
7.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.3 |
2.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 |
1.0 |
GO:0070120 |
brainstem development(GO:0003360) ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.3 |
1.0 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 |
2.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.3 |
5.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.3 |
12.3 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.3 |
0.9 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 |
1.3 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.3 |
0.9 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.3 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
1.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
1.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.6 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.3 |
4.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.3 |
1.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 |
0.3 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.3 |
1.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
2.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.3 |
0.9 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.3 |
1.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
1.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.3 |
0.9 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.3 |
2.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.3 |
5.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
0.3 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.3 |
0.3 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.3 |
3.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.3 |
1.5 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
5.1 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 |
1.2 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.3 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.3 |
0.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
1.8 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.3 |
8.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.3 |
0.6 |
GO:0060043 |
regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.3 |
1.5 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.3 |
2.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 |
0.3 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.3 |
0.9 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.3 |
1.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 |
0.3 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.3 |
8.6 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.3 |
2.0 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.3 |
1.7 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
2.9 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.3 |
0.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
3.4 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.3 |
2.8 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
0.3 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.3 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 |
0.3 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 |
0.6 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
0.3 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.3 |
0.6 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.3 |
2.8 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.3 |
2.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.3 |
0.8 |
GO:0045908 |
negative regulation of vasodilation(GO:0045908) |
| 0.3 |
1.4 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.3 |
0.3 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.3 |
2.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.3 |
1.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
1.1 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
0.5 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.3 |
0.3 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
0.5 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 |
0.3 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.3 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.3 |
5.0 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.3 |
0.8 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.3 |
0.3 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 |
1.0 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
1.0 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
2.1 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.3 |
0.3 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
1.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
0.8 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
0.5 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.3 |
5.1 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.3 |
1.0 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.3 |
0.5 |
GO:0055099 |
regulation of cholesterol esterification(GO:0010872) response to high density lipoprotein particle(GO:0055099) |
| 0.3 |
2.3 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.3 |
36.8 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
1.2 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.2 |
0.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.5 |
GO:0097155 |
embryonic heart tube left/right pattern formation(GO:0060971) fasciculation of sensory neuron axon(GO:0097155) |
| 0.2 |
0.7 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
1.2 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
0.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
1.5 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
0.5 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 |
3.1 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
0.7 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
1.0 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.2 |
2.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
1.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
1.0 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.2 |
1.9 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
1.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
2.1 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
1.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.2 |
1.4 |
GO:0021955 |
central nervous system neuron axonogenesis(GO:0021955) |
| 0.2 |
0.2 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 |
0.7 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
5.3 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.2 |
0.7 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
2.0 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 |
0.2 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
1.4 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 |
0.5 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.2 |
0.9 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.2 |
1.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
0.9 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.7 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
0.4 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.2 |
0.7 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
1.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
0.2 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
1.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
1.3 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
0.4 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 |
0.9 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.2 |
0.7 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 |
3.9 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.2 |
0.4 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.2 |
3.2 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.8 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
0.6 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
5.7 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.2 |
3.6 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.2 |
1.1 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.2 |
0.2 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.2 |
1.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
0.8 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.2 |
0.8 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.2 |
1.3 |
GO:0089711 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
3.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
1.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
1.4 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
0.2 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.2 |
1.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
4.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
1.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.2 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
1.0 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
1.0 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 |
0.4 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.2 |
0.2 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 |
1.4 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
5.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
1.6 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.6 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.2 |
0.6 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.2 |
0.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 |
1.0 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.6 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
1.2 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
1.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
5.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
1.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
1.7 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 |
4.8 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
0.7 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) |
| 0.2 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
1.3 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.2 |
0.4 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
0.4 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.2 |
0.6 |
GO:0036508 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.2 |
1.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
2.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
0.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
1.3 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 |
0.7 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.2 |
1.3 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
2.9 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
0.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
1.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
0.4 |
GO:0021612 |
facial nerve structural organization(GO:0021612) |
| 0.2 |
0.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
2.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 |
0.4 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.2 |
0.9 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 |
1.6 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
0.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.2 |
0.9 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.2 |
0.2 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
| 0.2 |
1.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
1.0 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
0.7 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.2 |
1.4 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 |
1.0 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
7.5 |
GO:0051963 |
regulation of synapse assembly(GO:0051963) |
| 0.2 |
1.0 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
1.7 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.2 |
0.7 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
1.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 |
0.5 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
0.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
3.7 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.2 |
0.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.5 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.5 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 |
0.5 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.2 |
0.8 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.2 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.2 |
0.8 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.2 |
0.2 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.2 |
0.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
9.8 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.2 |
1.0 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
0.3 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 |
0.8 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.2 |
0.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.2 |
0.3 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.2 |
0.3 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.2 |
0.8 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.2 |
0.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.2 |
0.8 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
0.3 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.2 |
0.9 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.2 |
0.3 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.2 |
0.5 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 |
0.9 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.2 |
0.5 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
0.3 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.9 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.4 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
0.9 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
2.4 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
0.1 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.1 |
0.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
2.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.9 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.3 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.6 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
1.4 |
GO:1902855 |
regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.1 |
0.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
3.6 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 |
0.1 |
GO:0003256 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
| 0.1 |
0.4 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 |
0.4 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.4 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 |
1.4 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.1 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.4 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.6 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.6 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.6 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
1.8 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.4 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.3 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.3 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
0.7 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.5 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
7.1 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.9 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
1.2 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.3 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
0.4 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.9 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.1 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.3 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
0.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
1.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.9 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.3 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.1 |
11.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.1 |
GO:0060699 |
regulation of endoribonuclease activity(GO:0060699) |
| 0.1 |
0.4 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.3 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.1 |
0.8 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.1 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
0.4 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
3.2 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.6 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.1 |
0.1 |
GO:0048291 |
isotype switching to IgG isotypes(GO:0048291) |
| 0.1 |
0.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
1.0 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
1.4 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.1 |
0.1 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
| 0.1 |
1.7 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.2 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 |
0.6 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
1.1 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.1 |
0.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.2 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.3 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 |
0.2 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.6 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.1 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.2 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
1.2 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.2 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.1 |
0.2 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.1 |
0.2 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.1 |
0.1 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.1 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.9 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.1 |
0.1 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.9 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.6 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.9 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.9 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
3.7 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.1 |
0.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.6 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
1.0 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
1.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
1.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 |
0.7 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
1.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
2.0 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.1 |
0.4 |
GO:1903392 |
negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
1.1 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.6 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.5 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
1.5 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.4 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
1.6 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
1.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
1.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.7 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.6 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 |
1.9 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
5.3 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
2.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.3 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.4 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.3 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.6 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
1.5 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 |
0.2 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
0.7 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.1 |
0.5 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.1 |
0.3 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.1 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.1 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
3.9 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.1 |
0.2 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.2 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
1.1 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
1.8 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
0.4 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
1.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
1.9 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
1.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.0 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.9 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.5 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.3 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.4 |
GO:2000303 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
1.6 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.9 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.1 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.1 |
1.6 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.6 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
7.4 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.5 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
1.3 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.1 |
GO:0010935 |
regulation of macrophage cytokine production(GO:0010935) |
| 0.1 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.4 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.9 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
1.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.3 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.1 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.1 |
1.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 |
0.3 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
0.5 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.1 |
0.2 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.4 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.2 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.1 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.1 |
GO:0051882 |
mitochondrial depolarization(GO:0051882) |
| 0.1 |
0.5 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.1 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.2 |
GO:0032232 |
negative regulation of actin filament bundle assembly(GO:0032232) |
| 0.1 |
0.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.4 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
1.9 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.1 |
0.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.1 |
GO:0055021 |
regulation of cardiac muscle tissue growth(GO:0055021) |
| 0.1 |
0.1 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.1 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.2 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
0.2 |
GO:0046113 |
beta-alanine metabolic process(GO:0019482) nucleobase catabolic process(GO:0046113) |
| 0.1 |
0.4 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
1.3 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.3 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
5.3 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.1 |
1.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 |
1.9 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.2 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
1.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
6.7 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.1 |
4.9 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
2.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.3 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
1.1 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.7 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.4 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.4 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.1 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.1 |
0.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.2 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 |
0.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.2 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.1 |
0.2 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.2 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.2 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.1 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.1 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.1 |
0.9 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
0.4 |
GO:0071622 |
regulation of granulocyte chemotaxis(GO:0071622) |
| 0.1 |
0.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.2 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.6 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
0.5 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.1 |
0.4 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.4 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.3 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.1 |
0.1 |
GO:0021855 |
hypothalamus cell migration(GO:0021855) |
| 0.1 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.3 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.4 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 |
0.3 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.4 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.2 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
0.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.5 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.0 |
0.4 |
GO:0019319 |
hexose biosynthetic process(GO:0019319) |
| 0.0 |
0.1 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.0 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
1.0 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.3 |
GO:0035308 |
negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 |
0.2 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.4 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.3 |
GO:0019359 |
NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.1 |
GO:0097061 |
dendritic spine organization(GO:0097061) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0099622 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.0 |
0.2 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.2 |
GO:0070076 |
histone lysine demethylation(GO:0070076) |
| 0.0 |
0.4 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.2 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.7 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.0 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.1 |
GO:0061718 |
NADH regeneration(GO:0006735) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.3 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.0 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.0 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.1 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.3 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.0 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.9 |
GO:0042073 |
intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.3 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.2 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.0 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.1 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
| 0.0 |
0.3 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.4 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.6 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.1 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.0 |
0.2 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.0 |
0.2 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.1 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.0 |
0.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.0 |
GO:0043987 |
histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.0 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.0 |
0.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.1 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.0 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.0 |
0.3 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.0 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.8 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.1 |
GO:0032490 |
detection of molecule of bacterial origin(GO:0032490) |
| 0.0 |
0.1 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.1 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.0 |
0.0 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.1 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 |
0.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.7 |
GO:0000226 |
microtubule cytoskeleton organization(GO:0000226) |
| 0.0 |
0.0 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 |
0.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.0 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.3 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 |
0.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.0 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.1 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.0 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.0 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.0 |
GO:0051193 |
regulation of cofactor metabolic process(GO:0051193) |
| 0.0 |
0.0 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.0 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
